Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE892 as Monotherapy and Combination Therapy in Participants With MTAP-Deleted Advanced Solid Tumors

NCT07277413 is registered in ClinicalTrials.gov with IDEAYA Biosciences as lead sponsor.

NCT NCT07277413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07277413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE892 as Monotherapy and Combination Therapy in Participants With MTAP-Deleted Advanced Solid Tumors
Lead sponsor
IDEAYA Biosciences
Phase
Phase 1
Overall status
Recruiting
Start date
March 4, 2026
Completion date
April 30, 2028
Enrollment
260 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of esophagus, biliary tract carcinoma, bladder cancer, gastric adenocarcinoma, gastroesophageal cancer (gc), mesothelioma, non-small cell lung cancer nsclc, nsclc adenocarcinoma, pancreatic cancer, peritoneal mesothelioma, pleural mesothelioma, squamous cell car. - esophagus, urothelial carcinoma (uc)